Aqsens Health and Equity Health Insurance sign a Memorandum of Understanding to deepen their collaboration in Ghana
Aqsens Health (Finland) and Equity Health Insurance (Ghana) signed a Memorandum of Understanding to accelerate market entry for AQ Malaria and other future tests for developing economies…
Updates from Ghana – Starting the E-TRF measurement of 2,800 malaria saliva samples
Aqsens Health and Noguchi Memorial Institute for Medical Research’s malaria screening test research project has been steadily moving ahead throughout 2022…
Using E-TRF to recognize deuterated compounds – Milja’s master’s thesis
Our Application Scientist Milja Virtanen finished her master’s thesis for Aqsens Health this autumn. Her MSc thesis in Chemistry focused on finding out if E-TRF can be used to differentiate between deuterated and non-deuterated compounds…
How E-TRF can help reveal new disease biomarkers
Accurate detection of severe diseases typically requires more than just one biomarker and their discovery is exceptionally troublesome. Aqsens Health aims to speed up the process. Our E-TRF method, modulators and measurement protocols are able to detect groups of biomarkers in a single measurement from biological samples…
Roosa nauha 2022 – Huonoennusteiset syövät
Maria Veitolan suunnittelemassa vuoden 2022 Roosa nauhassa näkyvät rintasyövän vaaleanpunaisen lisäksi myös muiden syöpien tunnusvärit: eturauhassyövän vaaleansininen, lapsuudenajan syövän kultainen, keuhkosyövän valkoinen, sekä esimerkiksi usein vaikean haimasyövän violetti…
Elizabeth’s Finnish summer
After having spend a few months in training in Finland between February and March of this year, Elizabeth Cudjoe traveled to Finland again in the summer for some more in-depth training…
Aqsens Health and OG Pharmaceuticals partner for an upcoming collaborative research project – Interview with OG Pharmaceuticals Founder & CEO Dr. Zhao Wanzhou
Dr. Zhao answered shared his views about the upcoming collaboration with Aqsens Health, the benefits of urine-based detection, and applying new cancer screening solutions in China.